(Q37734210)

22 August 2017

1 reference

title

Stem cell transplantation in multiple sclerosis: current status and future prospects (English)

1 reference

stem cell transplantation

22 August 2017

0 references

1 reference

Gianvito Martino

1

1 reference

22 August 2017

Robin J M Franklin

2

1 reference

22 August 2017

Anne Baron Van Evercooren

3

1 reference

22 August 2017

Douglas A Kerr

4

1 reference

22 August 2017

Stem Cells in Multiple Sclerosis (STEMS) Consensus Group

5

1 reference

22 August 2017

language of work or name

English

0 references

publication date

20 April 2010

1 reference

22 August 2017

Nature Reviews Neurology

1 reference

22 August 2017

6

1 reference

22 August 2017

5

1 reference

22 August 2017

247-255

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneurol.2010.35

22 August 2017

0 references

cites work

Adult neural stem cells expressing IL-10 confer potent immunomodulation and remyelination in experimental autoimmune encephalitis

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Autologous stem cell transplantation for progressive multiple sclerosis: Update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Autologous hematopoietic stem cell transplantation for autoimmune diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Autologous haematopoietic stem-cell transplantation in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

New directions in MS therapeutics: vehicles of hope

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Emerging multiple sclerosis disease-modifying therapies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Neuroprotection and repair

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Remyelination is extensive in a subset of multiple sclerosis patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Remyelination can be extensive in multiple sclerosis despite a long disease course

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Remyelination in the CNS: from biology to therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Persistent inflammation alters the function of the endogenous brain stem cell compartment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

From fish to man: understanding endogenous remyelination in central nervous system demyelinating diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Stem cells in inflammatory demyelinating disorders: a dual role for immunosuppression and neuroprotection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Mesenchymal stem cells in health and disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Immune regulatory neural stem/precursor cells protect from central nervous system autoimmunity by restraining dendritic cell function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Human neural stem cells ameliorate autoimmune encephalomyelitis in non-human primates.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Intraventricular transplantation of neural precursor cell spheres attenuates acute experimental allergic encephalomyelitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Transplanted neural precursor cells reduce brain inflammation to attenuate chronic experimental autoimmune encephalomyelitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Neuroprotective effect of transplanted human embryonic stem cell-derived neural precursors in an animal model of multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Neural precursor cells inhibit multiple inflammatory signals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Neural precursors attenuate autoimmune encephalomyelitis by peripheral immunosuppression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Transplanted multipotential neural precursor cells migrate into the inflamed white matter in response to experimental autoimmune encephalomyelitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Stem cell niche: structure and function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

The therapeutic potential of neural stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Non-hematopoietic bone marrow stem cells: molecular control of expansion and differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Human mesenchymal stem cells modulate B-cell functions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Adult mesenchymal stem cells for tissue engineering versus regenerative medicine.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Bone marrow cells regenerate infarcted myocardium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Neuronal differentiation potential of human adipose-derived mesenchymal stem cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Effects of direct transplantation of multipotent mesenchymal stromal/stem cells into the demyelinated spinal cord

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Bone marrow transplantation in low-grade non-Hodgkin's lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

The potential use of stem cells in multiple sclerosis: an overview of the preclinical experience

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

The development of neural stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Magnetic-resonance-based tracking and quantification of intravenously injected neural stem cell accumulation in the brains of mice with experimental multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Serial in vivo MR tracking of magnetically labeled neural spheres transplanted in chronic EAE mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Transplantation of CNS fragments into the brain of shiverer mutant mice: extensive myelination by implanted oligodendrocytes. I. Immunohistochemical studies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Repair of demyelinated lesions by transplantation of purified 0-2A progenitor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Adult brain retains the potential to generate oligodendroglial progenitors with extensive myelination capacity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Neonatal chimerization with human glial progenitor cells can both remyelinate and rescue the otherwise lethally hypomyelinated shiverer mouse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Myelination of the canine central nervous system by glial cell transplantation: a model for repair of human myelin disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Central remyelination restores secure conduction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Transplantation of glial cells enhances action potential conduction of amyelinated spinal cord axons in the myelin-deficient rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Locomotor deficits induced by experimental spinal cord demyelination are abolished by spontaneous remyelination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

To what extent is oligodendrocyte progenitor migration a limiting factor in the remyelination of multiple sclerosis lesions?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Human oligodendrocytes from embryonic stem cells: conserved SHH signaling networks and divergent FGF effects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Myelination following transplantation of EGF-responsive neural stem cells into a myelin-deficient environment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Neurotrophic cross-talk between the nervous and immune systems: implications for neurological diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

California institute to help stem-cell biotechs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Gene therapy: can neural stem cells deliver?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Olfactory ensheathing cells and CNS regeneration: the sweet smell of success?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Morphological and functional plasticity of olfactory ensheathing cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Schwann cell-like myelination following transplantation of an olfactory bulb-ensheathing cell line into areas of demyelination in the adult CNS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Identification of a human olfactory ensheathing cell that can effect transplant-mediated remyelination of demyelinated CNS axons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Transplanted olfactory ensheathing cells remyelinate and enhance axonal conduction in the demyelinated dorsal columns of the rat spinal cord.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Transplantation of human olfactory ensheathing cells elicits remyelination of demyelinated rat spinal cord

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Cryopreserved cells isolated from the adult canine olfactory bulb are capable of extensive remyelination following transplantation into the adult rat CNS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Survival and migration of human and rat olfactory ensheathing cells in intact and injured spinal cord.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Olfactory ensheathing cells induce less host astrocyte response and chondroitin sulphate proteoglycan expression than Schwann cells following transplantation into adult CNS white matter.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Autologous olfactory glial cell transplantation is reliable and safe in naturally occurring canine spinal cord injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Autologous olfactory ensheathing cell transplantation in human spinal cord injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Remyelination of CNS axons by Schwann cells transplanted from the sciatic nerve

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Cell-based remyelinating therapies in multiple sclerosis: evidence from experimental studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Boundary cap cells are highly competitive for CNS remyelination: fast migration and efficient differentiation in PNS and CNS myelin-forming cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Schwann cell precursors: a favourable cell for myelin repair in the Central Nervous System.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Skin-derived precursors generate myelinating Schwann cells for the injured and dysmyelinated nervous system.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

A highly enriched niche of precursor cells with neuronal and glial potential within the hair follicle dermal papilla of adult skin.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Cell-based interventions for neurologic conditions: ethical challenges for early human trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

New ISSCR guidelines underscore major principles for responsible translational stem cell research

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Axonal transection in the lesions of multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

The role of genetic factors in multiple sclerosis susceptibility.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Epidemiology of multiple sclerosis: a critical overview.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Epigenetic reprogramming and induced pluripotency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.35

Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20404843

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Polysialylated neural cell adhesion molecule-positive CNS precursors generate both oligodendrocytes and Schwann cells to remyelinate the CNS after transplantation.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20404843

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRNEUROL.2010.35

1 reference

22 August 2017

1 reference